NCT05471206

Evaluation of Gastrointestinal pH and Motility After the Consumption of Milk

Evaluation of Gastrointestinal pH and Motility by Using the SmartPill® Motility Capsules After the Consumption of Milk in Symptomatic Milk Intolerant and Asymptomatic Subjects

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 28 (actual)
• Sponsor: Lactalis · Industry
• Sex: All
• Age: 18 Years – 40 Years
• Healthy volunteers: Accepted

Summary

This pilot study is designed as a monocentric, open label, interventional, parallel arms, controlled clinical trial. The aim of the study is to assess the gastrointestinal pH and motility after the consumption of milk. The clinical study is categorized as an interventional research involving the human person with low risks and constraints (RIPH 2) and which does not assess a health product. The milk and medical device used in this clinical study are both authorized and already commercialized in France.

Conditions

• Healthy

Interventions

Type	Name	Description
OTHER	Milk and SmartPill intakes	During visit V2, the subject will ingest the SmartPill capsule. Then, subjects will drink milk.

Timeline

• Start date: 2022-11-24
• Primary completion: 2024-02-15
• Completion: 2024-02-15
• First posted: 2022-07-22
• Last updated: 2024-03-22

Locations

1 site across 1 country: France